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Noncoding variation of the gene for ferritin light chain in
hereditary and age-related cataract
Thomas M. Bennett,1 Giovanni Maraini,2 Chongfei Jin,3 Wenmin Sun,3 J. Fielding Hejtmancik,3 Alan Shiels1
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO; 2Department of
Ophthalmology, University of Parma, Parma, Italy; 3Ophthalmic Genetics and Visual Function Branch, National Eye Institute,
National Institutes of Health, Bethesda, MD
1

Purpose: Cataract is a clinically and genetically heterogeneous disorder of the ocular lens and an important cause of
visual impairment. The aim of this study was to map and identify the gene underlying autosomal dominant cataract
segregating in a four-generation family, determine the lens expression profile of the identified gene, and test for its association with age-related cataract in a case-control cohort.
Methods: Genomic DNA was prepared from blood leukocytes, and genotyping was performed by means of singlenucleotide polymorphism markers and microsatellite markers. Linkage analyses were performed using the GeneHunter
and MLINK programs, and mutation detection was achieved by dideoxy cycle sequencing. Lens expression studies were
performed using reverse-transcription polymerase chain reaction (RT–PCR) and in situ hybridization.
Results: Genome-wide linkage analysis with single nucleotide polymorphism markers in the family identified a likely
disease-haplotype interval on chromosome 19q (rs888861-[~17Mb]-rs8111640) that encompassed the microsatellite
marker D19S879 (logarithm of the odds score [Z]=2.03, recombination distance [θ]=0). Mutation profiling of positional-candidate genes detected a heterozygous, noncoding G-to-T transversion (c.-168G>T) located in the iron response
element (IRE) of the gene coding for ferritin light chain (FTL) that cosegregated with cataract in the family. Serum
ferritin levels were found to be abnormally elevated (~fourfold), without evidence of iron overload, in an affected family
member; this was consistent with a diagnosis of hereditary hyperferritinemia-cataract syndrome. No sequence variations located within the IRE were detected in a cohort of 197 cases with age-related cataract and 102 controls with clear
lenses. Expression studies of human FTL, and its mouse counterpart FTL1, in the lens detected RT–PCR amplicons
containing full-length protein-coding regions, and strong in situ localization of FTL1 transcripts to the lens equatorial
epithelium and peripheral cortex.
Conclusions: The data are consistent with robust transcription of FTL in the lens, and suggest that whereas variations
clustered in the IRE of the FTL gene are directly associated with hereditary hyperferritinemia-cataract syndrome, such
IRE variations are unlikely to play a significant role in the genetic etiology of age-related cataract.

color of opacity, making accurate phenotype-genotype correlations challenging [7]. The majority of underlying mutations
have been detected in 12 genes encoding alpha-, beta- and
gamma-crystallins, and connexins alpha-3 and alpha-8, with
the remainder of mutations found in a functionally diverse
group of genes including those for an aquaporin, a heatshock transcription factor, and intermediate filament-like
proteins [4-6]. Interestingly, there is increasing evidence that
variations in several of the genes underlying rare Mendelian
forms of cataract are also associated with much more frequent
forms of age-related cataract [6]. For example, coding and
noncoding variations in the genes for galactokinase deficiency (GALK1) and an ephrin receptor (EPHA2) have been
associated with age-related cataract in divergent populations
[8-12] providing new insights into the genetic complexity
of this universally important cause of low vision and blindness. Here, we have mapped autosomal dominant cataract
segregating in a Caucasian-American family to chromosome
19q, identified a recurrent mutation in the iron response

Hereditary forms of cataract constitute a clinically
and genetically heterogeneous disorder of the ocular lens
(OMIM). They are usually diagnosed at birth (congenital),
during infancy, or during childhood into adolescence, and
despite surgical treatment, are an important risk factor for
lifelong visual impairment [1-3]. In addition to being associated with many genetic syndromes and metabolic disorders involving other ocular and/or systemic abnormalities
(OMIM), cataract may be inherited as an isolated or primary
lens phenotype, often with autosomal dominant transmission
and high penetrance [4-6]. Currently, mutations in at least
22 genes have been linked with autosomal dominant and
recessive forms of primary cataract that variably affect all
or specific regions of the lens (e.g., nuclear, lamellar, sutural,
polar) and exhibit wide variation in size, shape, density, and
Correspondence to: Alan Shiels, Ophthalmology and Visual
Sciences, Box 8096 Washington University School of Medicine 660
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element (IRE) of the gene for ferritin light chain or L-ferritin
(FTL), localized expression of FTL in the lens, and evaluated
sequence variation of the FTL-IRE region in a case-control
cohort of age-related cataract.
METHODS
Family participants: A four-generation Caucasian-American
pedigree from the Midwestern United States was ascertained
through ophthalmic records in the Department of Ophthalmology and Visual Sciences at Washington University
School of Medicine. Blood samples were obtained from 13
family members, including six affected, four unaffected, and
three spouses. Leukocyte genomic DNA was purified using
the Gentra Puregene Blood kit (Qiagen, Valencia, CA), and
quantified by absorbance at 260 nm (NanoDrop 2000, Wilmington, DE). Ethical approval for this study was obtained
from the Washington University Human Research Protection
Office, and written informed consent was provided by all
participants before enrollment in accordance with the tenets
of the Declaration of Helsinki, as well as Health Insurance
Portability and Accountability Act regulations.
Case-control participants: A case-control cohort of unrelated
individuals aged >55 years from Northern Italy was ascertained from the Clinical Trial of Nutritional Supplements
and Age-Related Cataract Study [13]. Genomic DNA was
purified from blood samples using a standardized protocol
that included detergent lysis of cells and high salt precipitation of proteins followed by ethanol precipitation and phenol/
chloroform extraction of DNA as described [14]. Cataract
status (nuclear, cortical, posterior subcapsular, clear lens)
was evaluated by grading slit-lamp and retroillumination lens
photographs according to a modification of the Age-Related
Eye Disease Study cataract grading system as described [15].
Briefly, a lens was defined as clinically cataractous when
at least one type of opacity was present with the following
grades: nuclear opalescence >4.5 (range 0.9-8.1); cortical
opacity >25% inside the 5 mm diameter circle at the center
of the pupil and/or >25% outside the central 5 mm diameter
circle; posterior sub-capsular opacity >12.5% inside the
central 5 mm diameter circle. A clear lens was defined by
the following grades: nuclear opalescence <3.0; cortical
opacity <5% within the central 5 mm diameter circle, and
<15% outside the central 5 mm diameter circle; posterior subcapsular opacity <1.0% within the central 5 mm diameter
circle. Ethical approval for this study was obtained from
the University of Parma and the National Eye Institute, and
written informed consent was provided in accordance with
the tenets of the Declaration of Helsinki.
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Linkage analysis: For genome-wide linkage analysis, singlenucleotide polymorphism (SNP) genotyping was performed
by means of the GeneChip Human Mapping 10 K Array Xba
142 2.0 (Affymetrix, Santa Clara, CA), in the GeneChip Core
Facility at Washington University Siteman Cancer Center.
Parametric multipoint linkage analysis was performed using
an autosomal dominant model with GeneHunter Plus from the
easyLINKAGE Plus (v. 5.08) package [16]. SNP marker allele
frequencies used for linkage analysis were those calculated
for Caucasians by the HapMap project. A frequency of 0.0001
and a penetrance of 100% were assumed for the disease
allele. Computation was performed with GeneHunter Plus
(v.1.2) in sets of 100 markers using the AFFY 10 K deCODE
human genetic marker map. Confirmation of linkage was
achieved by genotyping microsatellite markers from the
NCBI combined Généthon, Marshfield, and deCODE genetic
linkage maps, as described [17]. Pedigree and haplotype data
were managed using Cyrillic (v. 2.1) software (FamilyGenetix Ltd., Reading, UK), and two-point logarithm of the odds
(LOD) scores (Z) calculated using the MLINK sub-program
from the LINKAGE (5.1) package of programs [18]. Marker
allele frequencies were assumed to be equal, and a frequency
of 0.0001 with a penetrance of 100% was assumed for the
disease allele.
Sequencing: Genomic sequence for lens intrinsic membrane
protein-2 (Gene ID: 3982) and FTL (Gene ID: 2512) were
obtained from the Ensembl human genome browser, and
gene-specific M13-tailed PCR primers (Table 1) were
selected from the NCBI resequencing amplicon probe database or custom designed with Primer Quest (IDT.com) or
Exon Primer (UCSC Genome Bioinformatics). Exons were
PCR amplified then cycle-sequenced in both directions
using BigDye Terminator Mix (v3.1) and a 3130×l-16 Genetic
Analyzer (Applied Biosystems, Foster City, CA), as described
[9].
Serum ferritin and plasma iron profile: Fasting blood samples
were collected by venipuncture into either anticoagulant-free
tubes for serum, or lithium heparin tubes for plasma (BD,
Franklin Lakes, NJ). Serum ferritin was measured by means
of chemiluminescence enzyme immunoassay (ADVIA
Centaur; Bayer, Pittsburg, PA). Plasma iron profile, including
iron, iron-binding capacity, and transferrin saturation, was
determined by colorimetric (Ferrochrome/Ferrozine) assay
(Roche Diagnostics, Indianapolis, IN). Transferrin saturation
(%) was calculated from iron concentration divided by total
iron binding capacity. Assays were conducted according to
Clinical Laboratory Improvement Amendments regulations
at Barnes-Jewish Hospital Laboratory.
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Table 1. PCR primers used for amplification of human FTL and LIM2, and mouse FTL1.
Primer

Location

Strand

Sequence (5′ - 3′)

FTL-IREF

5′-UTR

sense

ATTTCACAACACGCTGGCGCTACA

FTL-Ex1R

Intron-1

antisense

TCTGTTTACCCGACCGCACAAAGA

32G>TR

IRE

antisense

GTTCCGTCCAAACACTGTTGAAGA

FTL-Ex2F

Intron-1

sense

GAGTCCCCTTGGCCTCG

FTL-Ex2R

Intron-2

antisense

GACACCTACGCCCTCAAATC

FTL-Ex3F

Intron-2

sense

CCAACGACTCTTGGGAAATG

FTL-Ex3R

Intron-3

antisense

AAAGGGAGCAGAGGCTTGAG

FTL-Ex4F

Intron-3

sense

TCAGAGCCTCATTTCACACC

FTL-Ex4R

Exon-4

antisense

CCAACTCCTCTTTCACTGGC

FTL-Start

Exon-1

sense

ATGAGCTCCCAGATTCGTCAG

FTL-Stop

Exon-4

antisense

TTAGTCGTGCTTGAGAGTGAG

FTL1-Start

Exon-1

sense

ATGACCTCTCAGATTCGTCAG

FTL1-Stop

Exon-4

antisense

CTAGTCGTGCTTGAGAGTGAG

LIM2-Ex1F

Exon-1

sense

GGACTTCCAGGTTCTGAGCAAGG

LIM2-Ex1R

Intron-1

antisense

CGGACAAAGCCAGGGTTGCT

LIM2-Ex2F

Intron-1

sense

TGTGCATGACACCTCTGAAGCG

LIM2-Ex2R

Intron-2

antisense

GCATCCCACTCCTGAGCCCT

LIM2-Ex3F

Intron-2

sense

GCTGAGGTGGAAGCAGTCTTGC

LIM2-Ex3R

Intron-3

antisense

TTGCCAGGTGAAGAAGAGGGC

LIM2-Ex4F

Intron-3

sense

CCCAACACCCTACTCTCTTTCTCCC

LIM2-Ex4R

Intron-4

antisense

CCAAATATTGTTTCTCCCTCCCAGG

LIM2-Ex5F

Intron-4

sense

CCACCCTTACAGCTGTTTCTCCC

LIM2-Ex5R

Exon-5

antisense

CCCACATGAGTCCCACAGCA

Gene-specific primer-pairs used for amplification and sequencing of exons or transcripts.

Eye tissue collection and preparation: Mice (C57B6/J, postnatal day 21-28) were humanely killed by CO2 asphyxiation
followed by cervical dislocation. Eyes were removed and
fixed in 10% neutral buffered formalin (Fisher Scientific, Fair
Lawn, NJ) for 24 h at 20 °C before histology using standard
formaldehyde-fixed-paraffin-embedded (FFPE) techniques.
Alternatively, mouse eyes were placed in pre-warmed (37°C)
phosphate buffered saline (PBS; 10 mM phosphate buffer, 2.7
mM potassium chloride, 137 mM sodium chloride, pH 7.4)
and lenses dissected through a posterior incision in the globe
then stored (−20 °C) in RNAlater (Invitrogen, Carlsbad, CA).
Postmortem human lenses were obtained (frozen on dry ice)
from the Lions Eye Bank of Oregon. All tissue procurement
procedures were approved by the Washington University
Human Research Protection Office and Animal Studies
Committee, and conformed to the guidelines published by
the Institute for Laboratory Animal Research.
Reverse-transcription polymerase chain reaction: Total
cellular RNA was extracted from mouse and human lenses

by means of the RNeasy Plus Micro kit (Qiagen) and TRIzol
reagent (Invitrogen), respectively, then quantified by ultraviolet absorbance (ND2000, Nanodrop). Lens RNA (250 ng)
was reverse transcribed in the presence of random hexamers
with the iScript cDNA synthesis kit (Bio-Rad, Hercules,
CA), and cDNA products amplified (GeneAmp 9700 thermal
cycler, Applied Biosystems) with gene-specific primers
(Table 1) using Top-Taq reagents (Qiagen) according to the
manufacturer’s instructions. Reverse-transcription polymerase chain reaction (RT–PCR) amplicons were visualized
(302 nm) by electrophoresis on 2% agarose-gels stained with
GelRed (Biotium, Hayward, CA). Amplicon identity was
confirmed by sequencing as described above.
In situ hybridization: In situ hybridization (ISH) was
performed using the RNAscope 2.0 FFPE Reagent Kit RED (Advanced Cell Diagnostics, Inc. Hayward, CA) with
custom synthesized target probes designed for the mouse
FTL1 transcript (NM_010240.2, 986 bp mRNA), essentially as described [19]. The target probe region (6–908 bp)
837
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Figure 1. Linkage analysis of
autosomal dominant cataract found
to segregate in a four-generation
Caucasian-American pedigree. A:
Pedigree and haplotype analysis
shows segregation of SNP and
microsatellite markers on chromosome 19q, listed in descending
order from the centromere (19ptel). Squares and circles symbolize
males and females, respectively.
Filled symbols and bars denote
affected status and haplotypes,
respectively. B: Slit-lamp retroillumination image of a lens from
individual IV:3 before surgery at ~3
months of age reveals stellate opacities that appear as paler regions of
light scattering against the retinal red reflex. C: Ideogram of chromosome 19 indicates the location of the cataract locus (shaded gray) and
two positional candidate genes.

covered 5′-untranslated region (5′-UTR; 6–255 bp), coding
sequence (256–807 bp), and 3′-UTR (808–908 bp). Briefly,
FFPE microtome sections (5 µm, RM2255, Leica Microsystems, Buffalo Grove, IL) on glass slides (SuperFrost Plus)
were baked (1 h, 60 °C), dewaxed in xylene, dehydrated in
ethanol, boiled in citrate buffer, then protease treated (10 ug/
ml) in a HybEZ Oven (40 °C, 30 min). Pretreated sections
were hybridized with target probes (2 h, 40 °C), followed
by signal amplification oligonucleotides (15–30 min, 40 °C),
then alkaline phosphatase–conjugated Fast-Red label probe
(15–30 min, 20 °C). Labeled sections were treated with chromogenic Fast-Red substrate (10 min, 20 °C), counterstained
(Gill’s Hematoxylin-1/0.01% ammonia-H 2O), mounted
(Clear-Mount), and imaged under a bright-field microscope
(Olympus, BX51) fitted with a digital camera (Spot RT3).
RESULTS
Linkage analysis: We studied a four-generation Caucasian
pedigree from the Midwestern United States, segregating
star-shaped opacities affecting the lens nucleus and cortex
(Figure 1). Autosomal dominant inheritance was supported
by father-to-son transmission in the absence of generation
skipping. Ophthalmic records indicated that the cataract was
bilateral in the absence of other obvious ocular or systemic
abnormalities. Age at diagnosis varied from 0.5 to 25 years,
and age at surgery varied from 15 to 63 years. Postsurgical

corrected visual acuity varied from 20/20 to 20/30 in the
better eye.
For genome-wide linkage analysis, the six affected and
seven unaffected family members were genotyped by means
of the GeneChip Mapping 10 K 2.0 Array, which comprises
10,204 SNP markers uniformly spaced at a mean intermarker
distance of 258 kb, with an average heterozygosity of 0.38.
Parametric multipoint analysis detected suggestive evidence
of a linkage between SNP markers rs1366444 and rs2241721
(parametric LOD score 2.37) on chromosome 19q (Figure 2).
Haplotype reconstruction detected two obligate recombinant
individuals in the pedigree who defined a common disease
interval that cosegregated with cataract in all six affected
individuals (Figure 1A and Table 2). An unaffected female
(III:5) was recombinant at rs888861, and an affected female
(IV:3) was recombinant at rs8111640. However, no further
recombinant individuals were detected at other intervening
markers, consistent with the cataract locus residing in the
physical interval, rs888861-(~17 Mb)-rs8111640 (chr19:
35,381,852 - 52,621,644; Figure 1C). To further validate the
SNP haplotype on 19q, all 13 family members were regenotyped with microsatellite markers in the region. We obtained
confirmatory evidence of linkage at marker D19S879
(Zmax=2.03, θmax=0), which lies within the SNP interval (Table
2).
Mutation analysis: The disease interval contained over 840
positional candidate genes (NCBI Map Viewer), two of
838
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Table 2. Two -point logarithm of the odds scores (Z) were calculated for linkage
between the cataract locus and markers on chromosome 19q.
Marker (recombinant)

Mb

rs888861 (III:5)
D19S220

Z at recombination fraction (Θ)=
0.00

0.05

0.10

0.20

0.30

0.40

ZMax

ΘMax

35.38

-∞

−0.64

−0.38

−0.16

−0.06

−0.01

0.00

0.50

38.43

1.66

1.51

1.35

1.01

0.66

0.30

1.66

0.00

rs9304618

43.47

1.77

1.63

1.49

1.15

0.77

0.37

1.77

0.00

D19S412

47.01

1.18

1.11

1.02

0.83

0.60

0.32

1.18

0.00

FTL-IRE c.-168G>T

49.47

2.01

1.82

1.62

1.22

0.80

0.38

2.01

0.00

D19S879

49.52

2.03

1.85

1.67

1.27

0.84

0.40

2.03

0.00

rs10500307

52.07

1.91

1.73

1.55

1.17

0.77

0.37

1.91

0.00

rs8111640 (IV:3)

52.62

-∞

−0.39

−0.15

0.04

0.08

0.06

0.08

0.31

D19S571 (IV:3)

53.30

-∞

0.79

0.91

0.82

0.57

0.25

0.91

0.11

Z values for markers on 19q are listed in physical order measured in mega base pairs (Mb) from the short-arm telomere (19ptel).

which have been associated with inherited forms of cataract.
Sequencing of exons and intron boundaries first excluded
the presence of coding or splice-site mutations in the gene
for lens intrinsic membrane protein-2, which has been linked
with autosomal recessive cataract [20,21]. However, we
detected a heterozygous G-to-T transversion in exon-1 of the
gene for FTL that was not present in the wild type (Figure
3). The change (c.-168G>T) was located in the 5′-UTR at
nucleotide 168 upstream from the A (numbered +1) of the
translation start-site (ATG), and within the IRE at nucleotide 32 numbered from the consensus transcription startsite (32G>T). Allele-specific PCR analysis confirmed that
the T-allele cosegregated with affected, but not unaffected
family members (Figure 3C). Further, when we tested the
c.-168G>T transversion as a biallelic marker with a notional
allelic frequency of 1% in a two-point LOD score analysis of

the cataract locus (Table 2), we obtained further evidence of
linkage (Zmax=2.01, θmax=0). In addition, we confirmed that
the c.-168G>T transversion was not listed in the NCBI SNP
database (dbSNP), and excluded it as an SNP in a panel of 192
normal unrelated individuals (i.e., 384 chromosomes) using
the allele-specific PCR analysis described in Figure 3C (data
not shown). While it is possible that an undetected mutation
lay elsewhere within the disease-haplotype interval, our
genotype data strongly suggested that the c.-168G>T transversion in exon-1 of FTL represented a causative mutation
rather than a benign SNP in linkage disequilibrium with the
cataract phenotype.
Serum ferritin and iron status: To gain a better differential
diagnosis for autosomal dominant cataract cosegregating with
an FTL-IRE mutation, we undertook Clinical Laboratory
Improvement Amendments–certified testing of serum ferritin

Figure 2. Parametric multipoint
logarithm of the odds (pLOD MPT)
scores were calculated for linkage
between the cataract phenotype and
single nucleotide polymorphism
(SNP) markers across the genome.
Chromosome length is shown in
centi-Morgans (cM).
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chromosome 6p [OMIM ID: 235200]. Moreover, four other
genetic forms of hemochromatosis (HFE2A, HFE2B, HFE3,
HFE4) were excluded, since they are associated with iron
overload linked to genes other than FTL (OMIM ID: 608374,
606464, 604720, 604653).
Iron response element variants in age-related cataract
case controls: To investigate the possibility that sequence
variations in the FTL-IRE region are associated with agerelated cataract, we performed amplicon resequencing in 197
cases with age-related cataract and 102 age/gender-matched
controls with clear lenses. While no sequence variations in
the IRE of cases and controls were found (data not shown),
we detected a heterozygous G-to-A transition (c.-346G>A)
located upstream of the transcription start site in one case
with age-related cortical cataract (Appendix 1). However,
the serum ferritin levels and iron status of this individual
were unknown. Similarly, a heterozygous C>A transversion
located 216 nucleotides upstream of the IRE transcription
start site has been reported in a cataract patient of uncertain
ferritin and iron status [22]. In addition, at least 19 other variants in the immediate 5′-UTR of the FTL gene (Appendix 1)
have been documented in dbSNP, one of which (rs11553230)
is located within the IRE (c.-174T>C, 26T>C). However, their
clinical significance is not known.

Figure 3. Mutation analysis was performed on the ferritin light
chain – iron response element sequence. A: Sequence trace of the
wild-type allele shows G at nucleotide 168 upstream from the ATG
(c.-168G). B: Sequence trace of the mutant allele shows the heterozygous c.-168G>T transversion (denoted K by the International
Union of Pure and Applied Chemistry code). C: Allele-specific
PCR analysis using the three primers (Table 1) indicated by arrows
in the schematic diagram, reveals that the mutant T-allele (277 bp)
co-segregates with affected but not unaffected family members.

and iron profile in one available, affected family member
(III:4). She was found to have an abnormally high serum
ferritin level of 1208 µg/l (expected range 10–291 µg/l).
However, her serum iron level of 66 µg/dl (range 30–160 µg/
dl), total iron binding capacity value of 293 µg/dl (range
220–420 µg/dl), and calculated transferrin saturation value
of 23% (range 20%–50%) were all well within the normal
adult female range, and were consistent with a diagnosis of
hereditary hyperferritinemia-cataract syndrome (HHCS,
OMIM ID: 134790). The absence of an abnormal iron profile
formally excluded the possibility of classical hereditary
hemochromatosis, an autosomal recessive inborn error of
iron metabolism characterized by elevated serum ferritin
levels, transferrin saturation values >50%, iron overload,
and variations in the hemochromatosis (HFE) gene linked to

Human ferritin light chain and mouse ferritin light chain-1
transcripts in the lens: To determine the expression profile
of human FTL and its mouse counterpart, FTL1, in the lens
we undertook RT–PCR amplification and ISH analyses. RT–
PCR confirmed that the full-length coding regions for human
FTL (codons 1–175 + stop) and mouse FTL1 (codons 1–183
+ stop) could be amplified from human and mouse lenses,
respectively (Figure 4D). ISH revealed that FTL1 messenger
RNA (mRNA) transcripts are most strongly expressed in the
equatorial epithelium and peripheral cortical fiber cells of
the young (postnatal day 21) mouse lens, with much lower
levels detected in other eye tissues (Figure 4). This preferred
expression profile of the lens is consistent with FTL1 transcript levels detected by microarray analysis of mouse eye
tissues [23].
DISCUSSION
In this study, we have identified a Caucasian-American
family segregating HHCS. Since it was first described in
1995 [24-27], HHCS has been reported in over 70 families
or individuals mostly of European descent, with a minimum
estimated prevalence of 1/200,000 [28]. Mutations underlying HHCS are all clustered in the IRE of the FTL gene
(Appendix 1 and Appendix 2). This motif comprises approximately 75 nucleotides of the 5′-UTR, that when transcribed
840
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Figure 4. Mouse ferritin light
chain-1 (FTL1) and human ferritin
light chain (FTL) transcripts are
expressed in the lens. A: Low
magnif ication image (sagittal
plane) of the mouse eye (postnatal
day 21) shows strong localization
of ferritin light chain-1 (FTL1)
transcripts (red punctate staining)
to the equatorial epithelium and
peripheral cortical fiber cells of the
lens (Co - cornea, CB - ciliary body,
and iris, Le - lens, Re - retina). B
and C: High-magnification images
of FTL1 transcripts expressed in
the lens anterior epithelium (B)
and equatorial “bow” region (C).
Scale bars represent 100 µm. Cell
nuclei are stained blue. D: Reversetranscription polymerase chain
reaction (RT–PCR) analysis of lens
RNA detects amplicons containing
complete coding sequence for FTL and FTL1. Note the FTL1 amplicon (184 codons) is expected to be slightly larger than that of FTL (176
codons).

into mRNA, folds into a hairpin-like secondary structure
with a characteristic hexanucleotide loop joining the 5′- and
3′-stem regions generated by Watson–Crick base pairing
[29,30]. The FTL-IRE mutation spectrum comprises at least
34 heterozygous mutations, including 27 single nucleotide or
point changes, two compound heterozygous changes, and five
deletions ranging from 2 to 29 bp (Appendix 1 and Appendix
2). The most prevalent mutations occur in the 5′-stem and
hexanucleotide loop regions. The c.-168G>T (32G>T) change
described here is located in the 5′-stem region, adjacent to
the unpaired cytosine “bulge” (c.-167C, 33C), and recurrent
variations at this site have been reported in at least 17 other
families of European ancestry and one of Indian descent,
making it one of the most prevalent mutation sites in the IRE
[28,31-36]. Outside of the IRE, rare mutations in the coding
region of FTL have been associated with either neuroferritinopathy or hyperglycosylated serum ferritin associated with
benign hyperferritinemia in the absence of cataract [37-40].
HHCS has been shown to result from disruption of the
iron-dependent translational control of FTL gene expression.
Specifically, HHCS mutations have been shown to alter the
secondary structure and thermodynamic stability of the
FTL-IRE stem-loop structure, and to reduce its binding
affinity for cytoplasmic iron regulatory proteins (IRP1, IRP2)
that actively repress FTL translation [29,41,42]. Notably,

molecular modeling predicts that the FTL-IRE mutation
found here disrupts base-pairing between c.-168G (32G)
in the 5′-stem and c.-150C (50C) in the 3′-stem, inducing
altered base pairing within the upper stem and hexaloop
regions [32]. Further, protein binding assays have confirmed
that the same c.-168G>T mutation significantly reduced IRP
binding affinity in vitro [29,31]. Such mutation-induced
loss of IRE-IRP interaction is expected to result in elevated
levels of FTL biosynthesis, and large crystalline deposits of
immunoreactive L-ferritin have been observed in lens tissue
recovered from HHCS patients following cataract surgery
[32,42,43]. Our expression data show that FTL transcription
is higher in the lens compared with other eye tissues (Figure
4), and further support the concept that even in the presence
of a wild-type FTL-IRE allele, a mutant FTL-IRE allele
causes autosomal dominant cataract through uncontrolled
(derepressed) translation of L-ferritin.
While HHCS is generally associated with childhood
onset of cataract, there is considerable variation in the appearance and progression of lens opacities (Appendix 2), and many
patients do not undergo cataract surgery until middle age and
beyond. Such observations raise the possibility that FTL-IRE
sequence variations may also contribute to the etiology of
age-related cataract. Our sequencing data excluded IRE
variations in a European cohort with clinically well-defined
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age-related cortical, nuclear, and posterior subcapsular lens
opacities. A similar study also failed to detect evidence
for acquired somatic mutations in the FTL-IRE sequence
of DNA extracted from lens capsular material recovered
following age-related cataract surgery in an Israeli cohort
[34]. In contrast, we detected a heterozygous G>A transition
(c.-346G>A) located 147 nucleotides upstream of the IRE
that was not listed in the SNP databases in a patient with
age-related cortical cataract but unknown serum ferritin or
iron status. Another variation (C>A) located 216 nucleotides
upstream of the IRE transcription start site has been associated with elevated levels of FTL mRNA in lymphocytes from
a cataract patient also of undisclosed serum ferritin and iron
status [22]. In summary, while FTL-IRE variations clearly
underlie HHCS, they do not appear to be frequently associated with age-related cataract in Europeans. Further studies
will be required to determine the significance of FTL 5′-UTR
and promoter variations located outside the IRE in the genetic
etiology of age-related cataract.
APPENDIX 1. GENETIC VARIATION IN THE IRON
RESPONSE ELEMENT (IRE) AND IMMEDIATE
FLANKING 5´-UNTRANSLATED REGION (5´-UTR)
OF THE FERRITIN LIGHT CHAIN (FTL) GENE.
A: Schematic of FTL-IRE sequence (shaded) showing location of point-mutations (red), deletions >6bp (bold), deletions
2–6bp (bold-underline), and 19 variants, listed in dbSNP
(green). The IRE sequence spans ~75 nucleotides between
−125c and −199 g, and forms a hairpin-like structure in
transcribed mRNA with 5′- and 3′- stem regions (gray), a
hexa-nucleotide loop (yellow), and unpaired 5′-stem regions
(cyan). The first base, A, of the translation start-site (ATG) is
numbered +1. The transcription start-site is located at nucleotide −199 g and is numbered 1 in blue. Ex1->=start of exon-1
at nucleotide −282a. B: Sequence alignment of human (Hs)
versus mouse (Mm) IRE showing six mismatches (red) in the
5′- and 3′- stem regions but not in the loop region (yellow).
To access the data, click or select the words “Appendix 1.”
APPENDIX 2. MUTATION SPECTRUM OF THE
FERRITIN LIGHT CHAIN-IRON RESPONSE
ELEMENT (FTL-IRE) SEQUENCE ON 19Q13.4.
To access the data, click or select the words “Appendix 2.”
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